Faculty profile
Cheryl Arrowsmith
Back to facultyResearch
Read how they describe their research on their University of Toronto profile.
Latest papers
Site-Specific Hydrogen-Deuterium Exchange Mass Spectrometry for Deep Explorations of Dynamic Shifts in Protein-Drug Interactions.
Journal of the American Chemical Society · 2026
An Atlas of Short Linear Motif-Mediated Human Protein-Protein Interactions.
bioRxiv : the preprint server for biology · 2026
A synergistic interaction between PRMT5 and LSD1 inhibitors in AML.
Science advances · 2026
Latest funding
- $140,000
Characterization of the role of the NSD2 methyltransferase for SCLC progression
CIHR · 2025 · Supervisor
- $1,147,500
Finding vulnerabilities in advanced breast cancer from the chromatin state of repeat DNA
CIHR · 2025 · Co-investigator
- $140,000
Mapping and Modulating Airway Type II Transmembrane Serine Protease Activity to Identify Antiviral Drug Targets
CIHR · 2025 · Supervisor
34 publications.
Site-Specific Hydrogen-Deuterium Exchange Mass Spectrometry for Deep Explorations of Dynamic Shifts in Protein-Drug Interactions.
Anacleto J, Wolf E, Ackloo S, Arrowsmith C, LeBlanc Y, Lento C, Wilson DJ
An Atlas of Short Linear Motif-Mediated Human Protein-Protein Interactions.
Madhu P, Benz C, Simonetti L, Winters MJ, Subbanna MS, Kliche J, Gomez-Lucas L, Kotb HM, Krystkowiak I, Segal D, Darling WTP, Larsen-Ledet S, Vieler M, Zupancic A, Konstantinou A, Mihalic F, Varga JK, Pagano L, Lüchow S, Kraemer A, Ellingboe L, Görlitz K, Righetto GL, Kossmann C, Xiong R, Schueler-Furman O, Halabelian L, Santhakumar V, Arrowsmith C, Knapp S, Erdelyi M, Stein A, Vincentelli R, Pryciak PM, Davey NE, Ivarsson Y
A synergistic interaction between PRMT5 and LSD1 inhibitors in AML.
Param NJ, Arceci E, Fiorentino F, Pignata L, Torre D, Gutiérrez-Trejo N, Fong JY, Goy PA, Han BY, Lambona C, Di Bello E, Castiello C, Barone M, Schwarz M, Arrowsmith C, Ito K, Scherle P, Wee DKB, Ndoye S, Tabaglio T, Jeyasekharan AD, Lakshmanan M, Cirilli R, Habisch H, Madl T, Mattevi A, Valente S, Mai A, Guccione E
Development of a Dual Chemical Probe for the USP16 and HDAC6 Zinc-Finger Ubiquitin-Binding Domain.
Silva M, Mann M, Mirabi B, Szewczyk MM, Loup J, Dupeux A, Chandrasekaran R, Bajohr J, Arrowsmith C, Schapira M, Lautens M, Barsyte-Lovejoy D, Harding RJ, Santhakumar V
CACHE Challenge #3: Targeting the Nsp3 Macrodomain of SARS-CoV-2.
Herasymenko O, Silva M, Correy GJ, Abu-Saleh AAA, Ackloo S, Arrowsmith C, Ashworth A, Ban F, Beck H, Bishop KP, Bohórquez HJ, Bolotokova A, Breznik M, Chau I, Chen Y, Cherkasov A, Dehaen W, Della Corte D, Denzinger K, Doering NP, Edfeldt K, Edwards A, Fayne D, Gentile F, Gibson E, Gokdemir O, Gunnarsson A, Günther J, Irwin JJ, Jensen JH, Harding RJ, Hillisch A, Hoffer L, Hogner A, Hutchinson A, Kandwal S, Karlova A, Koirala K, Kotelnikov S, Kozakov D, Lee J, Lee S, Lessel U, Liu S, Liu X, Loppnau P, Meiler J, Moretti R, Moroz YS, Muvva C, Oprea TI, Paige B, Pandit A, Park K, Poda G, Protopopov MV, Pütter V, Ravichandran R, Rognan D, Rosta E, Sabnis Y, Scott T, Seitova A, Sharma P, Sindt F, Song M, Steinmann C, Stevens R, Talagayev V, Tararina VV, Tarkhanova O, Tingey D, Trant JF, Treleaven D, Tropsha A, Walters P, Wells J, Westermaier Y, Wolber G, Wortmann L, Zheng S, Fraser JS, Schapira M
Site-Specific Hydrogen Deuterium Exchange Difference Mass Spectrometry Measurements for Ligand Binding.
Anacleto J, Ackloo S, Arrowsmith C, Wolf E, Leblanc Y, Lento C, Wilson DJ
CACHE Challenge #2: Targeting the RNA Site of the SARS-CoV-2 Helicase Nsp13.
Herasymenko O, Silva M, Abu-Saleh AAA, Ahmad A, Alvarado-Huayhuaz J, Arce OEA, Armstrong RJ, Arrowsmith C, Bachta KE, Beck H, Berta D, Bieniek MK, Blay V, Bolotokova A, Bourne PE, Breznik M, Brown PJ, Campbell ADG, Carosati E, Chau I, Cole DJ, Cree B, Dehaen W, Denzinger K, Dos Santos Machado K, Dunn I, Durai P, Edfeldt K, Edwards A, Fayne D, Felfoldi D, Friston K, Ghiabi P, Gibson E, Günther J, Gunnarsson A, Hillisch A, Houston DR, Jensen JH, Harding RJ, Harris KS, Hoffer L, Hogner A, Horton JT, Houliston S, Hultquist JF, Hutchinson A, Irwin JJ, Jukič M, Kandwal S, Karlova A, Katis VL, Kich RP, Kireev D, Koes D, Inniss NL, Lessel U, Liu S, Loppnau P, Lu W, Martino S, McGibbon M, Meiler J, Mettu A, Money-Kyrle S, Moretti R, Moroz YS, Muvva C, Newman JA, Obendorf L, Paige B, Pandit A, Park K, Perveen S, Pirie R, Poda G, Protopopov M, Pütter V, Ricci F, Roper NJ, Rosta E, Rzhetskaya M, Sabnis Y, Satchell KJF, Schmitt Kremer F, Scott T, Seitova A, Steinmann C, Talagayev V, Tarkhanova OO, Tatum NJ, Treleaven D, Velasque Werhli A, Walters WP, Wang X, Wells J, Wells G, Westermaier Y, Wolber G, Wortmann L, Zhang J, Zhao Z, Zheng S, Schapira M
Chemical arsenal for helicase Hunters: Striking the toughest targets in antiviral research.
Martin HJ, Hossain MA, Wellnitz J, Kelestemur E, Hochuli JE, Perveen S, Arrowsmith C, Willson TM, Muratov EN, Tropsha A
Targeting PRC2 Enhances the Cytotoxic Capacity of Anti-CD19 CAR T Cells against Hematologic Malignancies.
Rodrigues Carvalho ML, de Oliveira Andrade C, Cabral-Piccin MP, Kinker GS, Vitiello GAF, Gonçalves Cambuí RA, de Macedo Abdo L, Mannarino Correia E, da Silva Elias BD, Araujo EVO, Chaves AS, Pereira PHB, Hajdu KL, Rondinelli A, Fagotti Gusmão A, Marques Pierre ML, Brasil-Costa I, Pouza Zanella C, Moreira Lemos MM, Batista MV, Filho JS, Arrowsmith C, Cordeiro de Lima VC, Bonamino MH, da Silva Medina T
Functionally active modulators targeting the LRRK2 WD40 repeat domain identified by FRASE-bot in CACHE Challenge #1.
Mettu A, Glavatskikh M, Wang X, Lara Ordóñez AJ, Li F, Chau I, Ackloo S, Arrowsmith C, Bolotokova A, Ghiabi P, Gibson E, Halabelian L, Houliston S, Harding RJ, Hutchinson A, Loppnau P, Perveen S, Seitova A, Zeng H, Schapira M, Taymans JM, Kireev D
Characterization of the role of the NSD2 methyltransferase for SCLC progression
Principal investigators: Horvath, Riley
Keywords: Epigenetic; H3k36 Methylation; Lung Cancer; Methyltransferase; Neuroendocrine Cancer; Nsd2; Protac; Small Cell Lung Cancer
Finding vulnerabilities in advanced breast cancer from the chromatin state of repeat DNA
Principal investigators: Lupien, Mathieu
Keywords: Breast Cancer; Chromatin; Epigenetic; Plasticity; Regulatory Elements; Repetitive Dna; Single-Cell Multiome; Transcription Factor; Transposable Elements
Mapping and Modulating Airway Type II Transmembrane Serine Protease Activity to Identify Antiviral Drug Targets
Principal investigators: Fraser, Bryan
Keywords: Antivirals; Chemical Biology; Drug Discovery; Pandemic Preparedness; Proteases; Proteomics; Structural Biology; Virus-Host Interactions
ProtacID to assess PROTAC specificity and map endogenous protein-protein interactions
Principal investigators: Raught, Brian
Keywords: Bioid; Mass Spectrometry; Protac; Proteomics
Investigating the mechanism of arginine methyltransferase PRMT1 in regulating mRNA splicing and as a therapeutic target against small cell lung cancer
Principal investigators: Lok, Benjamin
Keywords: Arginine Methyltransferase; Chemotherapy; Dna Damage; Dna Repair; Mrna Splicing; Novel Therapeutics; R-Loops; Radiation Therapy; Small Cell Lung Cancer
Finding vulnerabilities in breast cancer from the state of chromatin accessibility at transposable elements
Principal investigators: Lupien, Mathieu
Keywords: Breast Cancer; Chromatin; Epigenetic; Plasticity; Regulatory Elements; Repetitive Dna; Single-Cell Multiome; Transcription Factor; Transposable Elements
Structural and Chemical Biology of Targeted Degraders of NSD2
Principal investigators: Arrowsmith, Cheryl H
Keywords: Biochemistry; Epigenetics; Structural Biology; Targeted Protein Degradation (Protacs)
Targeting PRMT1 in Clear Cell Renal Cell Carcinoma
Principal investigators: Ailles, Laurie E
Keywords: Clear Cell Renal Cell Carcinoma; Dna Damage Response; Patient-Derived Models; Prmt1
Structural and Chemical Biology of Targeted Degraders of NSD2
Principal investigators: Arrowsmith, Cheryl H
Keywords: Biochemistry; Epigenetics; Structural Biology; Targeted Protein Degradation
The characterization and application of a novel chemical degrader of NSD2 for the development of anti-cancer therapeutics
Principal investigators: Nie, David Y
Keywords: Bioid; Cancer Epigenetics; Chemical Probe; Drug Design; Drug Technology; Epigenomics; Histone Methyltransferase; Nsd2; Protac; Targeted Protein Degradation
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
Frequent collaborators
- Medical Biophysics
- Department of Medical Biophysics
- Terrence Donnelly Centre for Cellular and Biomolecular Research
- Structural Genomics Consortium
- Pharmacology and Toxicology
- Chemical Engineering and Applied Chemistry
- Research Institute
- Other
Co-authors at University of Toronto, colored by department. Thicker lines mean more shared papers; select anyone to open their profile and their own map.
Matthieu Schapira
Structural Genomics Consortium
7 shared papers, latest 2026
Dalia Barsyte-Lovejoy
Pharmacology and Toxicology
4 shared papers, latest 2026
Aled Edwards
Terrence Donnelly Centre for Cellular and Biomolecular Research
3 shared papers, latest 2026
Mathieu Lupien
Medical Biophysics
2 shared papers, latest 2019
Razqallah Hakem
Faculty
2 shared papers, latest 2023
Brian Raught
Research Institute
2 shared papers, latest 2023
Ming-Sound Tsao
Department of Laboratory Medicine and Pathobiology
2 shared papers, latest 2021
Alexei Savchenko
Chemical Engineering and Applied Chemistry
2 shared papers, latest 2017
Rennian Wang
Physiology and Pharmacology
1 shared papers, latest 2015
Antonio Finelli
Faculty
1 shared papers, latest 2023
Paul Boutros
Faculty
1 shared papers, latest 2011
Mark Minden
Medical Biophysics
1 shared papers, latest 2014
Adrian Sacher
Faculty
1 shared papers, latest 2021
Moulay Alaoui-Jamali
Faculty
1 shared papers, latest 2023
Alexei Savchenko
Microbiology and Infectious Diseases
1 shared papers, latest 2017
Igor Stagljar
Biochemistry
1 shared papers, latest 2021
Steven Gallinger
Medical Biophysics
1 shared papers, latest 2015
Igor Jurisica
Rheumatology
1 shared papers, latest 2011
Jean-Yves Masson
Faculty
1 shared papers, latest 2023
Karim Mekhail
Laboratory Medicine & Pathobiology
1 shared papers, latest 2023
Artem Cherkasov
Urologic Sciences
1 shared papers, latest 2026
Kevin Kain
Medicine
1 shared papers, latest 2007
Thomas Kislinger
Department of Medical Biophysics
1 shared papers, latest 2018
Stefan Hofer
Plastic Surgery
1 shared papers, latest 2018
Gordon Keller
Medical Biophysics
1 shared papers, latest 2015
Linda Penn
Medical Biophysics
1 shared papers, latest 2011
Nada Jabado
Pediatrics
1 shared papers, latest 2019
Laurie Ailles
Department of Medical Biophysics
1 shared papers, latest 2023
David Hedley
Medical Oncology
1 shared papers, latest 2014
Rama Khokha
Cancer Research
1 shared papers, latest 2018
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.
Profile data last refreshed on September 25, 2026 from the university directory, publication records and CIHR, NSERC and SSHRC funding.